Collaboration will harness the potential of non coding RNAs (ncRNAs) in regenerating heart tissue Ethris will contribute its proprietary SNaP LNP platform for precise ncRNA delivery while Heqet ...
HAMILTON, BERMUDA , July 05, 2023 (GLOBE NEWSWIRE) -- Heqet will test nanoparticles based on Altamira’s OligoPhore delivery platform in the regeneration of damaged heart tissue Altamira Therapeutics ...
Joint Development Agreement with Heqet Therapeutics for development of a non-viral vector therapy for cardiac regeneration 4basebio PLC (AIM: 4BB), the life sciences group focused on exploiting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results